All Work

Jon C. Ogg

Hope of a BlackBerry Co-founders Rival Bid: From Hype to Despair

ThinkstockBlackBerry Ltd. (NASDAQ: BBRY) is highly troubled. News that more possible bidders are interested in competing against Fairfax Financial Holdings Ltd. (NYSE: FFH) to take the company private is surprising and obvious at the…

Jon C. Ogg · 13 years ago

Nomura Says to Sell Philip Morris International Now

ThinkstockPhilip Morris International Inc. (NYSE: PM) has experienced more than impressive growth in both its share price and its profits in the past four years. Lately its gains have petered out. The problem is…

Jon C. Ogg · 13 years ago

United Technologies Chases GE With Big Dividend Hike

Wikimedia CommonsConglomerates are supposed to be stable earnings due to diversified sources of income. That implies that they are supposed to have safe and growing dividends as well. Now we have news out that…

Jon C. Ogg · 13 years ago

FOMC Minutes: The Hawks Seemed Declawed

courtesy U.S. Federal ReserveThe Minutes from the September 17 to 18 FOMC meeting are not going to give the bulls nor the bears the smoking gun that they needed to build a case for…

Jon C. Ogg · 13 years ago

Our Take on HP Analyst Day: Higher Dividends, Much Higher

Does anyone truly care about it being the 2013 Securities Analyst Meeting for Hewlett-Packard Co. (NYSE: HPQ)? The stock market is so enthralled with the company that even the S&P Indexes group decided that…

Jon C. Ogg · 13 years ago

BofA Sees Big Upside in Regional Bank Competitors

ThinkstockIt is always interesting when bank analysts and brokerage firm analysts upgrade or downgrade their peers and competitors. The same is true for when they initiate research coverage. So what are investors supposed to…

Jon C. Ogg · 13 years ago

Janet Yellen Equals “Long Live Quantitative Easing”

Federalreserve.govNow that Janet Yellen is reportedly being appointed as the next chairman, or chairperson, of the Federal Reserve, the markets may get what they really wanted all along. Yellen represents a continuation of the…

Jon C. Ogg · 13 years ago

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

via Wikimedia CommonsAriad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that the FDA has placed a…

Jon C. Ogg · 13 years ago

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit Suisse’s Vamil Divan has…

Jon C. Ogg · 13 years ago

Alcoa Kicks Off Earnings Season Better Than Poorly

ThinkstockAlcoa Inc. (NYSE: AA) has just kicked off earnings season, and it was probably more than just a timing coincidence that Alcoa’s shares were downgraded this morning ahead of the numbers. Amazingly, the initial…

Jon C. Ogg · 13 years ago

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such, investors flock to the drug sector in times of uncertainty. But what about the…

Jon C. Ogg · 13 years ago

When Data Conflicts: Is the Malaria Vaccine Data Good or Bad?

ThinkstockA malaria vaccine is supposed to be a good thing. Right? Unfortunately that all depends. GlaxoSmithKline PLC (NYSE: GSK) currently plans to seek marketing approval for the first malaria vaccine next year. The British…

Jon C. Ogg · 13 years ago